Aakaar Medical Technologies Ltd vs Rainbow Childrens Medicare Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Aakaar Medical Technologies Ltd is ₹ 71.4 as of 16 Jun 15:30 . The P/E Ratio of Aakaar Medical Technologies Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Rainbow Childrens Medicare Ltd changed from 35.2 on March 2023 to 42.4 on March 2026 . This represents a CAGR of 4.76% over 4 years The Market Cap of Aakaar Medical Technologies Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Rainbow Childrens Medicare Ltd changed from ₹ 7412 crore on March 2023 to ₹ 11814 crore on March 2026 . This represents a CAGR of 12.36% over 4 years The revenue of Aakaar Medical Technologies Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Rainbow Childrens Medicare Ltd for the Jun '26 is ₹ 482.7 crore as compare to the Mar '26 revenue of ₹ 464.97 crore. This represent the growth of 3.81% The ebitda of Aakaar Medical Technologies Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Rainbow Childrens Medicare Ltd for the Jun '26 is ₹ 147.36 crore as compare to the Mar '26 ebitda of ₹ 148.23 crore. This represent the decline of -0.59% The net profit of Aakaar Medical Technologies Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of Rainbow Childrens Medicare Ltd changed from ₹ 39.73 crore to ₹ 62.54 crore over 9 quarters. This represents a CAGR of 22.34% The Dividend Payout of Aakaar Medical Technologies Ltd changed from 34.57 % on March 2022 to 0 % on March 2026 . This represents a CAGR of -100.00% over 5 yearsThe Dividend Payout of Rainbow Childrens Medicare Ltd changed from 13.22 % on March 2022 to 14.22 % on March 2026 . This represents a CAGR of 1.47% over 5 years .

About Aakaar Medical Technologies Ltd

Aakaar Medical Technologies Limited was originally incorporated as Aakaar Medical Technologies Private Limited', a private limited company dated June 20, 2013 issued by the Registrar of Companies, Mumbai.
Subsequently, Company status was converted into a public limited company and a fresh certificate of incorporation dated November 18, 2024 was issued by the Registrar of Companies, Mumbai, recording the change in the name of Company to Aakaar Medical Technologies Limited'. Incorporated in 2013, Aakaar Medicals are a medical aesthetic company dealing in a wide range of aesthetics & specialised cosmetic products & devices.
The Company supply its products & devices primarily to aesthetic physicians such as dermatologists, plastic surgeons, aesthetic physicians who sell these products to end consumers as well as use certain device consumables as part of their treatments.

About Rainbow Childrens Medicare Ltd

Rainbow Childrens Medicare Limited was originally incorporated as Rainbow Children's Medicare Private Limited' as Private Company dated August 7, 1998, issued by the Registrar of Companies, Hyderabad at Telangana.
Subsequently, the Company converted into a Public Limited, and name of the Company was changed to Rainbow Children's Medicare Limited' via fresh Certificate Incorporated issued by the RoC on November 20, 2021. The Company is a leading chain of multi-specialty pediatric, and obstetrics & gynecology hospitals in India, operating 23 hospitals and 5 outpatient clinic centers across 9 cities, with a total bed capacity of 2,375 beds.
The core specialties are Pediatrics and Obstetrics & Gynecology and emergency services.
Its Pediatric Services include newborn and pediatric intensive care, pediatric multi-specialty services, pediatric Quaternary care (including multi-organ transplants); whereas, Obstetrics & Gynecology services include normal and complex obstetric care, multi-disciplinary fetal care, perinatal genetic and fertility treatment.

FAQs for the comparison of Aakaar Medical Technologies Ltd and Rainbow Childrens Medicare Ltd

Which company has a larger market capitalization, Aakaar Medical Technologies Ltd or Rainbow Childrens Medicare Ltd?

Market cap of Aakaar Medical Technologies Ltd is 90 Cr while Market cap of Rainbow Childrens Medicare Ltd is 11,876 Cr

What are the key factors driving the stock performance of Aakaar Medical Technologies Ltd and Rainbow Childrens Medicare Ltd?

The stock performance of Aakaar Medical Technologies Ltd and Rainbow Childrens Medicare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aakaar Medical Technologies Ltd and Rainbow Childrens Medicare Ltd?

As of October 25, 2026, the Aakaar Medical Technologies Ltd stock price is INR ₹63.8. On the other hand, Rainbow Childrens Medicare Ltd stock price is INR ₹1169.3.

How do dividend payouts of Aakaar Medical Technologies Ltd and Rainbow Childrens Medicare Ltd compare?

To compare the dividend payouts of Aakaar Medical Technologies Ltd and Rainbow Childrens Medicare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.